MedTrace Logo

Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults

NCT00737412 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 277

Last updated 2010-01-21

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of Bio-K+ CL1285 in reducing traveler's diarrhea.

Conditions

Interventions

OTHER

Probiotic: Bio-K+ CL1285

The probiotic Bio-K+ CL1285 RX®, a mixture of Lactobacillus acidophilus and Lactobacillus casei, contains over 50 billion living bacteria per administered dose.

OTHER

Placebo

Matching capsules devoid of microorganisms

Sponsors & Collaborators

  • ethica Clinical Research Inc.

    collaborator INDUSTRY

  • Bio-K Plus International Inc.

    lead INDUSTRY

Principal Investigators

  • Dominique Tessier, MD · Sante Voyage Medisys

  • Benoit Brizard, MD · Clinique Santé Voyage de Laval

  • Benoit Cote, MD · Clinique Sante Voyage des Prairies

  • Jean Vincelette, MD · Sante Voyage Saint-Luc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-12-31
Completion
2010-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737412 on ClinicalTrials.gov